FAS and pancreatic adenocarcinoma: The majority of pancreatic adenocarcinoma cell lines is resistant to CD95 and TRAIL-mediated apoptosis despite expressing the corresponding death receptors at the cell surface (Ungefroren et al, 1998; Trauzold et al, 2001).